Plasma levels of olanzapine: Findings from an open-label study of adolescents and young adults with schizophrenia

被引：0
|
作者：
Dittmann, R [1 ]
Clement, H [1 ]
Knebel, W [1 ]
Roesch, F [1 ]
Hagenah, U [1 ]
Junghanss, J [1 ]
Maestele, A [1 ]
Mehler, C [1 ]
Meyer, C [1 ]
Pitzer, M [1 ]
Remschmidt, H [1 ]
Schlamp, D [1 ]
Schulte-Markwort, M [1 ]
Weiffenbach, O [1 ]
机构：
[1] Lilly Deutschland GmbH, Dept Med, Bad Homburg, Germany
来源：
SCHIZOPHRENIA BULLETIN | 2005年 / 31卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：481 / 481
页数：1
相关论文
共 50 条
  • [1] An open-label study of olanzapine in the first episode of schizophrenia in adolescents
    Dabokowska, M
    EUROPEAN PSYCHIATRY, 2002, 17 : 115S - 115S
  • [2] A prospective, open-label trial of olanzapine in adolescents with schizophrenia
    Findling, RL
    McNamara, NK
    Youngstrom, EA
    Branicky, LA
    Demeter, CA
    Schulz, SC
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2003, 42 (02): : 170 - 175
  • [3] Childhood-onset schizophrenia: An open-label study of olanzapine in adolescents
    Kumra, S
    Jacobsen, LK
    Rapoport, JL
    SCHIZOPHRENIA RESEARCH, 1998, 29 (1-2) : 149 - 149
  • [4] Childhood-onset schizophrenia: An open-label study of olanzapine in adolescents
    Kumra, S
    Jacobsen, LK
    Lenane, M
    Karp, BI
    Frazier, JA
    Smith, AK
    Bedwell, J
    Lee, P
    Malanga, CJ
    Hamburger, S
    Rapoport, JI
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1998, 37 (04): : 377 - 385
  • [5] Olanzapine efficacy and tolerability in adolescents with schizophrenia: results from an open-label extension phase
    Robertson-Plouch, Carol
    Kryzhanovskaya, Ludmila
    Schulz, Charles
    McDougle, Christopher
    Frazier, Jean
    Xu, Wen
    Carlson, Janice
    Tohen, Mauricio
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (06) : 879 - 879
  • [6] Olanzapine efficacy and tolerability in adolescents with schizophrenia: Results from an open-label extension phase
    Robertson-Plouch, Carol
    Kryzhanovskaya, Ludmila
    Schulz, Charles
    McDougle, Christopher J.
    Frazier, Jean A.
    Xu, Wen
    Carlson, Janice
    Tohen, Mauricio
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S215 - S216
  • [7] Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: An open-label pilot study
    Potenza, MN
    Holmes, JP
    Kanes, SJ
    McDougle, CJ
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (01) : 37 - 44
  • [8] Olanzapine in treatment-refractory schizophrenia: Results of an open-label study
    Martin, J
    Gomez, JC
    GarciaBernardo, E
    Cuesta, M
    Alvarez, E
    Gurpegui, M
    JOURNAL OF CLINICAL PSYCHIATRY, 1997, 58 (11) : 479 - 483
  • [9] Comments on "Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: An open-label pilot study
    Demb, HB
    Roychoudhury, K
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2000, 20 (05) : 580 - 581
  • [10] Effectiveness and tolerability of olanzapine in the treatment of adolescents with schizophrenia and related psychotic disorders:: Results from a large, prospective, open-label study
    Dittmann, Ralf W.
    Meyer, Eberhard
    Freisleder, Franz Joseph
    Remschmidt, Helmut
    Mehler-Wex, Claudia
    Junghanss, Jenny
    Hagenah, Ulrich
    Schulte-Markwort, Michael
    Poustka, Fritz
    Schmidt, Martin H.
    Schulz, Eberhard
    Maestele, Anneliese
    Wehmeier, Peter M.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2008, 18 (01) : 54 - 69
12345